Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells
Cegui Hu, Wen Qiao, Xiang Li, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 630-647.e8
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 14
Immunometabolism of CD8+ T cell differentiation in cancer
Hao Shi, Sidi Chen, Hongbo Chi
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 610-626
Closed Access | Times Cited: 15
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
Alessandro Mantovani, Amedeo Lonardo, Norbert Stefan, et al.
Metabolism (2024) Vol. 160, pp. 156014-156014
Closed Access | Times Cited: 11
Macrophages and T cells in metabolic disorder-associated cancers
Daniel Taranto, Daan J. Kloosterman, Leila Akkari
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
Kun Huang, Ying Han, Yihong Chen, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access | Times Cited: 1
A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1
Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective
Yang Xiao, Yongsheng Li, Huakan Zhao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy
Yukai Shan, Tian‐Ao Xie, Yuchao Sun, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
New insights into the role of complement system in colorectal cancer (Review)
Yu‐wen Xu, Jiaqi Zhou, Yuanyuan Wu, et al.
Molecular Medicine Reports (2025) Vol. 31, Iss. 3
Open Access
Serum FGF21 as predictor of response to atezolizumab and bevacizumab in HCC
Risako Kohya, Goki Suda, Masatsugu Ohara, et al.
JHEP Reports (2025) Vol. 7, Iss. 5, pp. 101364-101364
Open Access
Disrupting cholesterol homeostasis in T cells boosts antitumour responses
Kelly T. Kennewick, Steven J. Bensinger
Nature Metabolism (2025)
Closed Access
Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance
Andrew J. Kavran, Yulong Bai, Brian Rabe, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
Yongmei Wu, Wenqian Song, Su Min, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Suppressor of cytokine signaling 2 modulates regulatory T cell activity to suppress liver hepatocellular carcinoma growth and metastasis
Xi Lan, Heng Zhang, Z. Chen, et al.
World Journal of Gastroenterology (2025) Vol. 31, Iss. 13
Closed Access
Cholesterol effects on the tumor immune microenvironment: from fundamental concepts to mechanisms and implications
Francisco Alejandro Lagunas‐Rangel
Frontiers in Oncology (2025) Vol. 15
Open Access
The impact of metabolic reprogramming on tertiary lymphoid structure formation: enhancing cancer immunotherapy
Meng-Jie Zhang, Yan Wen, Zhi‐Jun Sun
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Metabolic Reprogramming of Glycolysis, Lipids, and Amino Acids in Tumors: Impact on CD8+ T Cell Function and Targeted Therapeutic Strategies
Panping Liang, Zedong Li, Zhengwen Chen, et al.
The FASEB Journal (2025) Vol. 39, Iss. 8
Closed Access
Dysregulation of cholesterol homeostasis in cancer pathogenesis
Aleksandra Mordzińska-Rak, Grégory Verdeil, Yannick Hamon, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
Tumor cell-intrinsic BIN1 deficiency promotes the immunosuppression and impedes ferroptosis of non-small cell lung cancer via G3BP1-mediated degradation of STAT1
Jiali Wang, Yunlong Jia, Tianxu Liu, et al.
Research Square (Research Square) (2025)
Closed Access
Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity
Michael J. Clowers, Zahraa Rahal, Sung-Nam Cho, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Rewiring lipid metabolism to enhance immunotherapy efficacy in melanoma: a frontier in cancer treatment
Xiong Li-hua, Jian Cheng
Frontiers in Oncology (2025) Vol. 15
Open Access
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma
Gregory Kenneth Muliawan, Terence K. Lee
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Targeting lipid metabolism via nanomedicine: a prospective strategy for cancer therapy
Xing Huang, Shengzhong Hou, Yinggang Li, et al.
Biomaterials (2024) Vol. 317, pp. 123022-123022
Closed Access | Times Cited: 2
tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells
Shan Miao, Hao Li, Xiaohan Song, et al.
The Journal of Experimental Medicine (2024) Vol. 222, Iss. 3
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top